<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <Volume-Issue>Volume 11, Issue 2</Volume-Issue>
      <Season>October - December 2020</Season>
          <FirstName>Raj Kishore</FirstName>
      <Abstract>Aim and Objectives: The objective of this study would be to evaluate spontaneous locomotor activity of aqueous extract of Azadirachtaindica in mice. Materials and Methods: This is an animal interventional study where 48 mice were divided to 8 groups. Each group was given the respective drug either aqueous extract of Azadirachtaindica or standard drug or control drug. Spontaneous locomotor activity was recorded before and after 10 days of administration of drugs using actophotometer. Results: There was no statistically significant difference in spontaneous locomotor activity of aqueous extract of Azadirachtaindica, standard drug and control drug before and after administration respectively. Conclusions: The results of this study clearly demonstrate that aqueous extract of Azadirachtaindica leaves doesn’t possess CNS psychostimulant activity or sedative action.</Abstract>
      <Keywords>Azadirachtaindica, psychostimulant</Keywords>
        <Abstract>https://njbms.in/ubijournal-v1copy/journals/abstract.php?article_id=13258&amp;title=EVALUATION OF SPONTANEOUS LOCOMOTOR ACTIVITY OF AQUEOUS EXTRACT OF AZADIRACHTAINDICA IN MICE</Abstract>
1. Kobayashi K, Shimizu N, Matsushita S, Murata T. The assessment of mouse spontaneous locomotor activity using motion picture. J Pharmacol Sci. 2020 Jun; 143(2):83-88.&#13;
2. S. Pellow, P. Chopin, S.E. File, M. Briley.Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 14 (3) (1985).&#13;
3. R.D. Porsolt, G. Anton, N. Blavet, M. Jalfre. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol, 47 (4) (1978).&#13;
4. R.G.M. Morris. Spatial localization does not require the presence of local cues. Learn Motiv, 12 (2) (1981).&#13;
5. Suresh K, Anupam S. Apigenin: The Anxiolytic Constituent of Turneraaphrodisiaca. Pharmaceutical Biology. 2006; 44(2): 84–90.&#13;
6. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of Depression. Neuron. 2002; 34: 13–25.&#13;
7. Zhang Z. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 2002; 70: 3077-96.&#13;
8. Thakur VD, Mengi SA, Neuropharmacological profile of Ecliptaalba (Linn.) Hassk. Journal of Ethnopharmacology.2005; 102: 23–31.&#13;
9. Mahesh R, Bhatt S, Devadoss T, Jindal AK, Gautam BK, Dhar AK, et al. Anti-depressant Like Effect of Novel 5-HT3 Receptor Antagonist,(4-benzylpiperazin-&#13;
1-yl) (3-methoxyquinoxalin-2-yl) methanone (6g) in Acute and Chronic Animal Models of Depression. IJPER.2013; 47: 71–81.&#13;
10. Shaikh BT, Hatcher J. Complementary and alternative medicine in Pakistan: Prospects and limitations. Evid Based Complement Alternat Med 2005; 2: 139-42.&#13;
11. Dorababu M, Joshi MC, Bhawani G, Mohan kumar M, Aditi C, Goel RK. Effect of aqueous extract of neem (azadirachta indica) leaves on offensive and diffensive gastric mucosal factors in rats. Indian J Physiol Pharmacol. 2006; 50(3):241–249.</References>